catumaxomab [clinicaltrials_resource:bdf251d337080de856c2f418b4160744]
intervention [clinicaltrials_vocabulary:intervention]
catumaxomab [clinicaltrials_resource:bdf251d337080de856c2f418b4160744]
Bio2RDF identifier
bdf251d337080de856c2f418b4160744
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:bdf251d337080de856c2f418b4160744
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
Catumaxomab administered as fo ...... , 20, 50, 150 microgram (mcg).
intervention name [clinicaltrials_vocabulary:intervention-name]
catumaxomab
other name [clinicaltrials_vocabulary:other-name]
identifier
clinicaltrials_resource:bdf251d337080de856c2f418b4160744
title
catumaxomab
@en
type
label
catumaxomab [clinicaltrials_resource:bdf251d337080de856c2f418b4160744]
@en